CPhI Istanbul Launches as Pharma's Gateway to the High-Growth Markets of Eurasia, Central Asia and MENA Regions

Istanbul (ots/PRNewswire) -

New event to act as regional confluence for 22 countries, with
Turkey's

domestic demand alone forecast to reach $22.8 billion by 2015

UBM Live has today announced the latest addition to its global
pharmaceutical events portfolio, CPhI Istanbul 2014
[http://www.cphi-istanbul.com ]. CPhI is the leading pharmaceutical
networking event and will take place on June 4th-6th 2014 at the
Lutfi Kirdar International Convention and Exhibition Centre in
Istanbul.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

The Eurasian region is on the precipice of exponential
pharmaceutical sector growth, with Turkey as a core country within
this region as growth is forecast to reach $16bilion by 2014. With
the event located in Istanbul, it acts as a central melting pot for
both the Turkish pharmaceutical sector, those in Eurasia, Central
Asia and MENA regions. There are also a significant number of
pharmaceutical companies operating in Istanbul, with exports to
neighbouring countries reflecting the highly regarded position
Istanbul holds within the market and it's potential to become a
foremost provider of pharmaceuticals.

Istanbul is the ideal geographical hub in the region between some
of the world's most dynamic pharma markets- with Turkey being the
OECDs fastest growing economy. As the confluence between Asia, Europe
and MENA, Istanbul serves as a meeting point for trade, with the
regional pharma market no exception, and is seen as the go-to
destination for pharmaceuticals. The exhibitor profile reflects this
diversity with 115 companies from key countries including exhibitors
from the region's largest healthcare economies of Israel, Egypt, and
Saudi Arabia.

CPhI Istanbul 2014 will provide the first centralised event for
regional drug manufacturers to meet with global suppliers of raw
materials, machinery, packaging solutions and contract services, as
well as attracting visitors from the region looking for suppliers and
manufacturing partners to bring cost-competitive pharmaceuticals to
their individual markets.

The event has formed a strategic partnership with the
Pharmaceutical Manufacturers Association of Turkey (IEIS
[http://www.ieis.org.tr/asp_pages/index.asp ]), who are exclusively
supporting the event and providing active promotion amongst their
members- emphasising the status that CPhI Istanbul holds as the
foremost trade fair for presenting new business opportunities for
pharmaceutical companies within the region.

What's more, 33 investment projects designed to develop new and
modernise existing pharmaceutical industries in the MENA and Central
Asia region will complete by 2015- with a total value of nearly
$400m. This commitment to creating reformed healthcare economies
represents a tremendous growth opportunity for private companies both
local and international- especially for higher-yield pharmaceutical
products where demand is rising rapidly, which is attracting the
attention of multinational Pharma companies.

Similarly, Turkey's pharmaceutical sector is currently ranked
seventh in Europe and 16th globally and the next few years are
predicted to be a very exciting time for investing, particularly as
healthcare spending in the country is predicted to rise over the next
year. Furthermore, the Turkish government is introducing financial
incentives in an attempt to increase attraction from international
drug producing companies, and exports are estimated to rise to a
potential $8 billion.

CPhI Istanbul, which will co-locate with P-MEC, InnoPack and ICSE,
will provide a new meeting point for bringing together senior pharma
professionals and international pharmaceutical suppliers and buyers
of pharma raw materials, machinery, packaging solutions and contract
services. Collaboratively, it is expected that the shows will attract
around 2,000 visitors, both local and international.

Highlights of CPhI Istanbul 2014:

- Co-location with P-MEC, InnoPack and ICSE providing services and
opportunities through the whole supply chain
- Conference programme, produced by UBM conferences featuring opinion leaders
from government, academia and industry with workshops, round tables and plenary
sessions
- A buyers programme to deliver high-value buyers in growing markets
- Invitation-only welcome reception and networking event
- Potential one-to-one partnering for visitors and exhibitors to provide new
leads and business partners

CPhI Istanbul 2014 will focus on pharma ingredients, with
exhibiting companies covering ingredients, APIs, fine chemicals,
excipients, biopharmaceuticals and more, whilst P-MEC will
successfully deliver innovative pharmaceutical equipment and
technology to a worldwide forum of decision makers. It is the
must-attend networking event for any business in the pharmaceutical
machinery, equipment and technology industry. InnoPack will also be
taking place, which offers the pharma community innovative and
diverse packaging and drug delivery solutions to satisfy the changing
way in which medication is packaged and delivered. Connecting the
pharmaceutical community with outsourcing solution providers is ICSE,
which provides a forum for business development, networking and
education.

Chris Kilbee, Group Director, CPhI Pharma Portfolio, commented on
the launch of the event: "CPhI Istanbul will provide an unrivalled
opportunity to act as central business hub for the 22 countries
within this region and help stimulate growth in what is already a
dynamic and readily reforming and modernising healthcare and pharma
market. With government support in the region on the rise, alongside
a rapidly changing healthcare landscape, the event launch marks a new
stage in positioning regional companies within a more global context.
CPhI Istanbul will bring together local Turkish drug manufacturers
with regional suppliers of raw materials and will undoubtedly help to
build and develop the region as a prime area for manufacturing both
locally and internationally."

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24
October, 2013 at Messe Frankfurt, Germany; CPhI and P-MEC India
(03-05 December, 2013 at the Bombay Exhibition Centre in Mumbai);
CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ; CPhI Russia and IPhEB
(16-17 April, 2014); CPhI, P-MEC and Innopack South East Asia (20-22
May, 2014 in Jakarta, Indonesia); CPhI, P-MEC, ISCE, InnoPack
Istanbul (4-6 June 1014 in Istanbul) CPhI, P-MEC, ICSE, InnoPack and
BioPh China (26-28 June 2014 in Shaghai) and CPhI, ICSE and BioPh
South America (05-07 August, 2014 at the Expo Center Norte in Sao
Paulo, Brazil).

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Russia, Istanbul and South America co-located with ICSE for
contract services, P-MEC for machinery, equipment & technology,
InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI
provides an online buyer & supplier directory at CPhI-Online.com and
hosts a global community with news and analysis at
PharmaEvolution.com.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de